PaxMedica (PXMD) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free PXMD Stock Alerts $0.33 -0.03 (-8.33%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | globenewswire.comPaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101May 14, 2024 | investorplace.comPXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024May 7, 2024 | markets.businessinsider.comPaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory StrategyMay 7, 2024 | finance.yahoo.comPaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory StrategyMay 3, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDAApril 26, 2024 | finance.yahoo.comPaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell PodcastApril 25, 2024 | theglobeandmail.comUrgent Action: PaxMedica (NASDAQ: PXMD) Addresses Medical Crisis in MalawiApril 25, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDAApril 23, 2024 | globenewswire.comPaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101April 18, 2024 | finanznachrichten.dePaxMedica, Inc.: PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping SicknessApril 12, 2024 | finanznachrichten.dePaxMedica, Inc.: PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 12, 2024 | markets.businessinsider.comNasdaq Down 300 Points; BlackRock Posts Upbeat EarningsApril 12, 2024 | msn.comPenny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock RalliesApril 12, 2024 | investorplace.comWhy Is PaxMedica (PXMD) Stock Up 93% Today?April 12, 2024 | investorplace.comWhy Is PaxMedica (PXMD) Stock Up 93% Today?April 11, 2024 | msn.comPaxMedica shares soar 125% post-market on drug updateApril 11, 2024 | finance.yahoo.comPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 11, 2024 | globenewswire.comPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 9, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) Developing Robust Product Lineup to Address ASD, Associated ConditionsMarch 23, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD PatientsMarch 13, 2024 | globenewswire.comPaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder TreatmentsMarch 6, 2024 | morningstar.comPaxMedica Inc Ordinary Shares PXMDFebruary 23, 2024 | benzinga.comPaxMedica Stock (NASDAQ:PXMD), Short Interest ReportJanuary 29, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASDJanuary 18, 2024 | finance.yahoo.comIBN Highlights PaxMedica's Video Release on Transformative ASD StudyJanuary 17, 2024 | theglobeandmail.comIBN Highlights PaxMedica’s (NASDAQ: PXMD) Video Release on Transformative ASD StudyJanuary 17, 2024 | finance.yahoo.comPaxMedica on Promising Path to Address Unmet ASD NeedsDecember 22, 2023 | finance.yahoo.comPaxMedica Files 8-K Following Nasdaq Compliance AchievementDecember 20, 2023 | finance.yahoo.comPaxMedica, Inc. (PXMD) Interactive Stock Chart - Yahoo FinanceDecember 19, 2023 | finance.yahoo.comPaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy PipelineDecember 12, 2023 | finance.yahoo.comPaxMedica Inc. Covered in H.C. Wainwright & Co. Research ReportDecember 8, 2023 | finance.yahoo.comPaxMedica CEO Featured in Just-Released Fireside Chat VideoDecember 6, 2023 | finance.yahoo.comPaxMedica Releases Fireside Chat Video with CEO Howard WeismanDecember 5, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy RecommendationDecember 4, 2023 | benzinga.comPaxMedica Stock (NASDAQ:PXMD), Analyst Ratings, Price Targets, PredictionsDecember 1, 2023 | finance.yahoo.comPaxMedica Closes on Public Offering Reaching Estimated $7MNovember 25, 2023 | finance.yahoo.comPaxMedica Announces Closing of $7.0 Million Public OfferingNovember 22, 2023 | finanznachrichten.dePaxMedica, Inc.: PaxMedica Announces Closing of $7.0 Million Public OfferingNovember 22, 2023 | finance.yahoo.comPaxMedica Announces Pricing of $7M Public OfferingNovember 22, 2023 | investorplace.comWhy Is PaxMedica (PXMD) Stock Up 57% Today?November 21, 2023 | finance.yahoo.comPaxMedica News of FDA Type-B Meeting Shared in Audio BroadcastNovember 20, 2023 | investorplace.comWhy Is PaxMedica (PXMD) Stock Down 40% Today?November 20, 2023 | finanznachrichten.dePaxMedica, Inc.: PaxMedica Announces Pricing of $7.0 Million Public OfferingNovember 20, 2023 | markets.businessinsider.comCrude Oil Gains Over 2%; PaxMedica Shares PlungeNovember 20, 2023 | msn.comWhy PaxMedica Stock (PXMD) Is Down Nearly 40% TodayNovember 20, 2023 | finance.yahoo.comPaxMedica Announces Pricing of $7.0 Million Public OfferingNovember 18, 2023 | ca.finance.yahoo.comPaxMedica, Inc. (PXMD) Stock Price, News, Quote & History - Yahoo FinanceNovember 17, 2023 | finance.yahoo.comPaxMedica Releases Q3 2023 Financial Report, Corporate UpdateNovember 17, 2023 | finance.yahoo.comPaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial DataNovember 15, 2023 | finance.yahoo.comPaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Do This Before July 30 2024 To Claim Trump’s Gift (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. PXMD Media Mentions By Week PXMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PXMD News Sentiment▼0.000.76▲Average Medical News Sentiment PXMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PXMD Articles This Week▼01▲PXMD Articles Average Week Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GRI News QLGN News NLSP News PRFX News DRMA News PBLA News ATNF News NBSE News ALLR News GLMD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PXMD) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
